nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—BCHE—peripheral nervous system neoplasm	0.378	0.719	CbGaD
Mefloquine—ABCB1—peripheral nervous system neoplasm	0.148	0.282	CbGaD
Mefloquine—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0414	0.201	CbGbCtD
Mefloquine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0264	0.128	CbGbCtD
Mefloquine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0264	0.128	CbGbCtD
Mefloquine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0183	0.0888	CbGbCtD
Mefloquine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0158	0.0768	CbGbCtD
Mefloquine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0147	0.0714	CbGbCtD
Mefloquine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0113	0.0547	CbGbCtD
Mefloquine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0105	0.051	CbGbCtD
Mefloquine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0103	0.0501	CbGbCtD
Mefloquine—HBA1—forelimb—peripheral nervous system neoplasm	0.00934	0.273	CbGeAlD
Mefloquine—HBA2—forelimb—peripheral nervous system neoplasm	0.00857	0.251	CbGeAlD
Mefloquine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00705	0.0342	CbGbCtD
Mefloquine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00676	0.0328	CbGbCtD
Mefloquine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00664	0.0322	CbGbCtD
Mefloquine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00619	0.03	CbGbCtD
Mefloquine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00422	0.0205	CbGbCtD
Mefloquine—ADORA2A—ganglion—peripheral nervous system neoplasm	0.00241	0.0706	CbGeAlD
Mefloquine—HBA1—brainstem—peripheral nervous system neoplasm	0.00219	0.0642	CbGeAlD
Mefloquine—ADORA1—nerve—peripheral nervous system neoplasm	0.00211	0.0617	CbGeAlD
Mefloquine—ADORA1—ganglion—peripheral nervous system neoplasm	0.00208	0.0609	CbGeAlD
Mefloquine—HBA1—cerebellum—peripheral nervous system neoplasm	0.00108	0.0316	CbGeAlD
Mefloquine—ADORA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00102	0.0299	CbGeAlD
Mefloquine—ACHE—trigeminal ganglion—peripheral nervous system neoplasm	0.00102	0.0297	CbGeAlD
Mefloquine—HBA2—cerebellum—peripheral nervous system neoplasm	0.000993	0.0291	CbGeAlD
Mefloquine—ADORA2A—cerebellum—peripheral nervous system neoplasm	0.000517	0.0151	CbGeAlD
Mefloquine—ACHE—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000501	0.00705	CbGpPWpGaD
Mefloquine—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	0.000499	0.0146	CbGeAlD
Mefloquine—CYP19A1—FSH signaling pathway—BDNF—peripheral nervous system neoplasm	0.000464	0.00654	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000455	0.00641	CbGpPWpGaD
Mefloquine—ADORA1—cerebellum—peripheral nervous system neoplasm	0.000446	0.0131	CbGeAlD
Mefloquine—ACHE—cerebellum—peripheral nervous system neoplasm	0.000443	0.013	CbGeAlD
Mefloquine—BCHE—brainstem—peripheral nervous system neoplasm	0.000442	0.0129	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000394	0.00555	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.000361	0.00508	CbGpPWpGaD
Mefloquine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000353	0.00496	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000351	0.00495	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000345	0.00486	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000332	0.00467	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GNS—peripheral nervous system neoplasm	0.000329	0.00463	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—NME1—peripheral nervous system neoplasm	0.000316	0.00444	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—COX2—peripheral nervous system neoplasm	0.000304	0.00427	CbGpPWpGaD
Mefloquine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000299	0.00421	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000294	0.00414	CbGpPWpGaD
Mefloquine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000293	0.00857	CbGeAlD
Mefloquine—ACHE—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000264	0.00371	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000258	0.00364	CbGpPWpGaD
Mefloquine—ACHE—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	0.000256	0.00361	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GNS—peripheral nervous system neoplasm	0.000249	0.00351	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—NME1—peripheral nervous system neoplasm	0.000239	0.00337	CbGpPWpGaD
Mefloquine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000238	0.00697	CbGeAlD
Mefloquine—HBA1—Metabolism—COX2—peripheral nervous system neoplasm	0.00023	0.00324	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000227	0.0032	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000224	0.00315	CbGpPWpGaD
Mefloquine—BCHE—cerebellum—peripheral nervous system neoplasm	0.000218	0.00638	CbGeAlD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000217	0.00306	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000215	0.00302	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000202	0.00284	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000199	0.00281	CbGpPWpGaD
Mefloquine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000193	0.00272	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000187	0.00264	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00018	0.00253	CbGpPWpGaD
Mefloquine—ACHE—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.000179	0.00252	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000173	0.00244	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000168	0.00237	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—peripheral nervous system neoplasm	0.000167	0.00235	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000166	0.00234	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000166	0.00234	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000161	0.00226	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—TH—peripheral nervous system neoplasm	0.000158	0.00223	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000157	0.00221	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000156	0.00219	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000156	0.00219	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000151	0.00213	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000145	0.00205	CbGpPWpGaD
Mefloquine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000144	0.00423	CbGeAlD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000143	0.00201	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00014	0.00198	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000139	0.00195	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000139	0.00195	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—peripheral nervous system neoplasm	0.000136	0.00191	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000134	0.00189	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000133	0.00187	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000132	0.00186	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000129	0.00182	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—NTRK2—peripheral nervous system neoplasm	0.000128	0.00181	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000128	0.0018	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000127	0.00179	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000127	0.00178	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000127	0.00178	CbGpPWpGaD
Mefloquine—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.000126	0.00177	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000122	0.00171	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—TH—peripheral nervous system neoplasm	0.00012	0.00169	CbGpPWpGaD
Mefloquine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000116	0.00164	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000115	0.00162	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000115	0.00162	CbGpPWpGaD
Mefloquine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000114	0.000702	CcSEcCtD
Mefloquine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000702	CcSEcCtD
Mefloquine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000114	0.000701	CcSEcCtD
Mefloquine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000114	0.000701	CcSEcCtD
Mefloquine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000114	0.000701	CcSEcCtD
Mefloquine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000114	0.000699	CcSEcCtD
Mefloquine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000114	0.000699	CcSEcCtD
Mefloquine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000698	CcSEcCtD
Mefloquine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000114	0.000698	CcSEcCtD
Mefloquine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000114	0.000698	CcSEcCtD
Mefloquine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000114	0.000697	CcSEcCtD
Mefloquine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000695	CcSEcCtD
Mefloquine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000695	CcSEcCtD
Mefloquine—Rash—Melphalan—peripheral nervous system neoplasm	0.000113	0.000693	CcSEcCtD
Mefloquine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000113	0.000692	CcSEcCtD
Mefloquine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00069	CcSEcCtD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000112	0.00158	CbGpPWpGaD
Mefloquine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000112	0.000687	CcSEcCtD
Mefloquine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000684	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000111	0.000682	CcSEcCtD
Mefloquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000111	0.00156	CbGpPWpGaD
Mefloquine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000111	0.000679	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00011	0.00155	CbGpPWpGaD
Mefloquine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000672	CcSEcCtD
Mefloquine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000109	0.000671	CcSEcCtD
Mefloquine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.00067	CcSEcCtD
Mefloquine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000667	CcSEcCtD
Mefloquine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000667	CcSEcCtD
Mefloquine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000109	0.000667	CcSEcCtD
Mefloquine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000108	0.000665	CcSEcCtD
Mefloquine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000108	0.000664	CcSEcCtD
Mefloquine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000663	CcSEcCtD
Mefloquine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000108	0.000661	CcSEcCtD
Mefloquine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000108	0.000661	CcSEcCtD
Mefloquine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000107	0.000659	CcSEcCtD
Mefloquine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000659	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000655	CcSEcCtD
Mefloquine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000654	CcSEcCtD
Mefloquine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000106	0.000653	CcSEcCtD
Mefloquine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000106	0.000653	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000106	0.00149	CbGpPWpGaD
Mefloquine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000646	CcSEcCtD
Mefloquine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000105	0.000645	CcSEcCtD
Mefloquine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000105	0.000643	CcSEcCtD
Mefloquine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000105	0.000643	CcSEcCtD
Mefloquine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000105	0.000643	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—NTRK1—peripheral nervous system neoplasm	0.000105	0.00147	CbGpPWpGaD
Mefloquine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000641	CcSEcCtD
Mefloquine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000104	0.00064	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000104	0.00146	CbGpPWpGaD
Mefloquine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000104	0.000637	CcSEcCtD
Mefloquine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000104	0.00304	CbGeAlD
Mefloquine—ACHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000103	0.00144	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000102	0.00144	CbGpPWpGaD
Mefloquine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000625	CcSEcCtD
Mefloquine—ACHE—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000102	0.00143	CbGpPWpGaD
Mefloquine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.000623	CcSEcCtD
Mefloquine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000622	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000621	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000101	0.00142	CbGpPWpGaD
Mefloquine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.0001	0.000616	CcSEcCtD
Mefloquine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000613	CcSEcCtD
Mefloquine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.87e-05	0.000605	CcSEcCtD
Mefloquine—HBA1—Metabolism—GNAS—peripheral nervous system neoplasm	9.8e-05	0.00138	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	9.78e-05	0.00138	CbGpPWpGaD
Mefloquine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.77e-05	0.000599	CcSEcCtD
Mefloquine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.74e-05	0.000597	CcSEcCtD
Mefloquine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.66e-05	0.000593	CcSEcCtD
Mefloquine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000591	CcSEcCtD
Mefloquine—HBA1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.62e-05	0.00135	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.6e-05	0.00135	CbGpPWpGaD
Mefloquine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.58e-05	0.000587	CcSEcCtD
Mefloquine—Somnolence—Etoposide—peripheral nervous system neoplasm	9.55e-05	0.000586	CcSEcCtD
Mefloquine—Asthenia—Vincristine—peripheral nervous system neoplasm	9.51e-05	0.000583	CcSEcCtD
Mefloquine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000582	CcSEcCtD
Mefloquine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.44e-05	0.000579	CcSEcCtD
Mefloquine—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.43e-05	0.00133	CbGpPWpGaD
Mefloquine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.42e-05	0.000577	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.000574	CcSEcCtD
Mefloquine—Rash—Dactinomycin—peripheral nervous system neoplasm	9.36e-05	0.000574	CcSEcCtD
Mefloquine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.000573	CcSEcCtD
Mefloquine—Renal failure—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000569	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.27e-05	0.000569	CcSEcCtD
Mefloquine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.27e-05	0.000568	CcSEcCtD
Mefloquine—Fatigue—Etoposide—peripheral nervous system neoplasm	9.26e-05	0.000568	CcSEcCtD
Mefloquine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000568	CcSEcCtD
Mefloquine—BCHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.15e-05	0.00129	CbGpPWpGaD
Mefloquine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.1e-05	0.000558	CcSEcCtD
Mefloquine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.07e-05	0.000556	CcSEcCtD
Mefloquine—Sweating—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000555	CcSEcCtD
Mefloquine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000548	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	8.88e-05	0.00125	CbGpPWpGaD
Mefloquine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.85e-05	0.000543	CcSEcCtD
Mefloquine—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.82e-05	0.000541	CcSEcCtD
Mefloquine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.00054	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.81e-05	0.00124	CbGpPWpGaD
Mefloquine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000539	CcSEcCtD
Mefloquine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.78e-05	0.000539	CcSEcCtD
Mefloquine—Dizziness—Vincristine—peripheral nervous system neoplasm	8.77e-05	0.000538	CcSEcCtD
Mefloquine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.75e-05	0.000537	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.72e-05	0.00123	CbGpPWpGaD
Mefloquine—Rash—Alitretinoin—peripheral nervous system neoplasm	8.68e-05	0.000532	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTPN11—peripheral nervous system neoplasm	8.67e-05	0.00122	CbGpPWpGaD
Mefloquine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.67e-05	0.000532	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000531	CcSEcCtD
Mefloquine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.64e-05	0.00053	CcSEcCtD
Mefloquine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000529	CcSEcCtD
Mefloquine—Headache—Alitretinoin—peripheral nervous system neoplasm	8.62e-05	0.000529	CcSEcCtD
Mefloquine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000527	CcSEcCtD
Mefloquine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000525	CcSEcCtD
Mefloquine—Urticaria—Etoposide—peripheral nervous system neoplasm	8.53e-05	0.000523	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	8.51e-05	0.0012	CbGpPWpGaD
Mefloquine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.49e-05	0.000521	CcSEcCtD
Mefloquine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.49e-05	0.000521	CcSEcCtD
Mefloquine—Vomiting—Vincristine—peripheral nervous system neoplasm	8.43e-05	0.000517	CcSEcCtD
Mefloquine—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.41e-05	0.000516	CcSEcCtD
Mefloquine—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000514	CcSEcCtD
Mefloquine—Rash—Vincristine—peripheral nervous system neoplasm	8.36e-05	0.000513	CcSEcCtD
Mefloquine—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.35e-05	0.000512	CcSEcCtD
Mefloquine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000511	CcSEcCtD
Mefloquine—Headache—Vincristine—peripheral nervous system neoplasm	8.31e-05	0.000509	CcSEcCtD
Mefloquine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000507	CcSEcCtD
Mefloquine—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.17e-05	0.000501	CcSEcCtD
Mefloquine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000501	CcSEcCtD
Mefloquine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.0005	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	8.05e-05	0.00113	CbGpPWpGaD
Mefloquine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.02e-05	0.000492	CcSEcCtD
Mefloquine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000491	CcSEcCtD
Mefloquine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.00049	CcSEcCtD
Mefloquine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.92e-05	0.000486	CcSEcCtD
Mefloquine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.91e-05	0.000485	CcSEcCtD
Mefloquine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000485	CcSEcCtD
Mefloquine—Nausea—Vincristine—peripheral nervous system neoplasm	7.88e-05	0.000483	CcSEcCtD
Mefloquine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000482	CcSEcCtD
Mefloquine—Flushing—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000482	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	7.78e-05	0.00109	CbGpPWpGaD
Mefloquine—Asthenia—Etoposide—peripheral nervous system neoplasm	7.71e-05	0.000473	CcSEcCtD
Mefloquine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000473	CcSEcCtD
Mefloquine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000472	CcSEcCtD
Mefloquine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000468	CcSEcCtD
Mefloquine—Chills—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000466	CcSEcCtD
Mefloquine—Pruritus—Etoposide—peripheral nervous system neoplasm	7.6e-05	0.000466	CcSEcCtD
Mefloquine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000463	CcSEcCtD
Mefloquine—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000459	CcSEcCtD
Mefloquine—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.46e-05	0.000457	CcSEcCtD
Mefloquine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000455	CcSEcCtD
Mefloquine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000455	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	7.41e-05	0.00104	CbGpPWpGaD
Mefloquine—Rash—Cisplatin—peripheral nervous system neoplasm	7.39e-05	0.000453	CcSEcCtD
Mefloquine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.39e-05	0.000453	CcSEcCtD
Mefloquine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000452	CcSEcCtD
Mefloquine—Erythema—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000452	CcSEcCtD
Mefloquine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.35e-05	0.000451	CcSEcCtD
Mefloquine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000449	CcSEcCtD
Mefloquine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000448	CcSEcCtD
Mefloquine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000446	CcSEcCtD
Mefloquine—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000446	CcSEcCtD
Mefloquine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000436	CcSEcCtD
Mefloquine—Dizziness—Etoposide—peripheral nervous system neoplasm	7.1e-05	0.000436	CcSEcCtD
Mefloquine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000435	CcSEcCtD
Mefloquine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000433	CcSEcCtD
Mefloquine—Chills—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000431	CcSEcCtD
Mefloquine—Nausea—Cisplatin—peripheral nervous system neoplasm	6.97e-05	0.000427	CcSEcCtD
Mefloquine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000426	CcSEcCtD
Mefloquine—ACHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.93e-05	0.000976	CbGpPWpGaD
Mefloquine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000425	CcSEcCtD
Mefloquine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000421	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	6.85e-05	0.000965	CbGpPWpGaD
Mefloquine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.00042	CcSEcCtD
Mefloquine—Vomiting—Etoposide—peripheral nervous system neoplasm	6.83e-05	0.000419	CcSEcCtD
Mefloquine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000419	CcSEcCtD
Mefloquine—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000419	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	6.8e-05	0.000957	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.8e-05	0.000956	CbGpPWpGaD
Mefloquine—Agitation—Epirubicin—peripheral nervous system neoplasm	6.78e-05	0.000416	CcSEcCtD
Mefloquine—Rash—Etoposide—peripheral nervous system neoplasm	6.77e-05	0.000415	CcSEcCtD
Mefloquine—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.77e-05	0.000415	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	6.73e-05	0.000947	CbGpPWpGaD
Mefloquine—Headache—Etoposide—peripheral nervous system neoplasm	6.73e-05	0.000413	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	6.67e-05	0.000939	CbGpPWpGaD
Mefloquine—Malaise—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000408	CcSEcCtD
Mefloquine—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000406	CcSEcCtD
Mefloquine—Syncope—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000406	CcSEcCtD
Mefloquine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000405	CcSEcCtD
Mefloquine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000402	CcSEcCtD
Mefloquine—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.0004	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.51e-05	0.000917	CbGpPWpGaD
Mefloquine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000398	CcSEcCtD
Mefloquine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000395	CcSEcCtD
Mefloquine—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000392	CcSEcCtD
Mefloquine—Nausea—Etoposide—peripheral nervous system neoplasm	6.38e-05	0.000391	CcSEcCtD
Mefloquine—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000391	CcSEcCtD
Mefloquine—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.37e-05	0.000897	CbGpPWpGaD
Mefloquine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000388	CcSEcCtD
Mefloquine—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000385	CcSEcCtD
Mefloquine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000385	CcSEcCtD
Mefloquine—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000385	CcSEcCtD
Mefloquine—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000385	CcSEcCtD
Mefloquine—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000384	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000383	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.21e-05	0.000874	CbGpPWpGaD
Mefloquine—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000381	CcSEcCtD
Mefloquine—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.18e-05	0.00087	CbGpPWpGaD
Mefloquine—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000378	CcSEcCtD
Mefloquine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000376	CcSEcCtD
Mefloquine—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000375	CcSEcCtD
Mefloquine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000375	CcSEcCtD
Mefloquine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.000372	CcSEcCtD
Mefloquine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.00037	CcSEcCtD
Mefloquine—Oedema—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000369	CcSEcCtD
Mefloquine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000369	CcSEcCtD
Mefloquine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000368	CcSEcCtD
Mefloquine—Shock—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000363	CcSEcCtD
Mefloquine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000363	CcSEcCtD
Mefloquine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000362	CcSEcCtD
Mefloquine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000362	CcSEcCtD
Mefloquine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000361	CcSEcCtD
Mefloquine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.00036	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.85e-05	0.000824	CbGpPWpGaD
Mefloquine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000359	CcSEcCtD
Mefloquine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000357	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.82e-05	0.000818	CbGpPWpGaD
Mefloquine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000356	CcSEcCtD
Mefloquine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000356	CcSEcCtD
Mefloquine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000356	CcSEcCtD
Mefloquine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000355	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000354	CcSEcCtD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.76e-05	0.000811	CbGpPWpGaD
Mefloquine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000352	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.69e-05	0.000801	CbGpPWpGaD
Mefloquine—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000345	CcSEcCtD
Mefloquine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000344	CcSEcCtD
Mefloquine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000342	CcSEcCtD
Mefloquine—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000342	CcSEcCtD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	5.51e-05	0.000776	CbGpPWpGaD
Mefloquine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000336	CcSEcCtD
Mefloquine—Shock—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000336	CcSEcCtD
Mefloquine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000335	CcSEcCtD
Mefloquine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000335	CcSEcCtD
Mefloquine—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000334	CcSEcCtD
Mefloquine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000333	CcSEcCtD
Mefloquine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000332	CcSEcCtD
Mefloquine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000332	CcSEcCtD
Mefloquine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.00033	CcSEcCtD
Mefloquine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000329	CcSEcCtD
Mefloquine—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000328	CcSEcCtD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.33e-05	0.00075	CbGpPWpGaD
Mefloquine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000325	CcSEcCtD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.29e-05	0.000745	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.28e-05	0.000743	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	5.27e-05	0.000742	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.27e-05	0.000742	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.25e-05	0.000738	CbGpPWpGaD
Mefloquine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000321	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	5.21e-05	0.000734	CbGpPWpGaD
Mefloquine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000319	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000319	CcSEcCtD
Mefloquine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000318	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.17e-05	0.000727	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.15e-05	0.000725	CbGpPWpGaD
Mefloquine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000311	CcSEcCtD
Mefloquine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000309	CcSEcCtD
Mefloquine—ADORA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.03e-05	0.000708	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	5.02e-05	0.000707	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GNS—peripheral nervous system neoplasm	5.01e-05	0.000705	CbGpPWpGaD
Mefloquine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000307	CcSEcCtD
Mefloquine—ACHE—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	4.98e-05	0.000701	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.98e-05	0.0007	CbGpPWpGaD
Mefloquine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000305	CcSEcCtD
Mefloquine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000304	CcSEcCtD
Mefloquine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000304	CcSEcCtD
Mefloquine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000302	CcSEcCtD
Mefloquine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000301	CcSEcCtD
Mefloquine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000297	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000295	CcSEcCtD
Mefloquine—ACHE—Metabolism—NME1—peripheral nervous system neoplasm	4.8e-05	0.000676	CbGpPWpGaD
Mefloquine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000295	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—CASP3—peripheral nervous system neoplasm	4.78e-05	0.000673	CbGpPWpGaD
Mefloquine—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000293	CcSEcCtD
Mefloquine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000292	CcSEcCtD
Mefloquine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000292	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.75e-05	0.000669	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.66e-05	0.000655	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—COX2—peripheral nervous system neoplasm	4.62e-05	0.000651	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	4.61e-05	0.000648	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	4.6e-05	0.000647	CbGpPWpGaD
Mefloquine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000282	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	4.57e-05	0.000643	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000279	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.52e-05	0.000636	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	4.47e-05	0.000629	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.47e-05	0.000629	CbGpPWpGaD
Mefloquine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000272	CcSEcCtD
Mefloquine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000271	CcSEcCtD
Mefloquine—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	4.42e-05	0.000621	CbGpPWpGaD
Mefloquine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00027	CcSEcCtD
Mefloquine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00027	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.39e-05	0.000618	CbGpPWpGaD
Mefloquine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000265	CcSEcCtD
Mefloquine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.3e-05	0.000605	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	4.29e-05	0.000603	CbGpPWpGaD
Mefloquine—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000261	CcSEcCtD
Mefloquine—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	4.25e-05	0.000598	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.21e-05	0.000592	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	4.13e-05	0.000581	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.12e-05	0.00058	CbGpPWpGaD
Mefloquine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000253	CcSEcCtD
Mefloquine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000252	CcSEcCtD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.07e-05	0.000573	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—NRAS—peripheral nervous system neoplasm	4.01e-05	0.000564	CbGpPWpGaD
Mefloquine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000245	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.99e-05	0.000562	CbGpPWpGaD
Mefloquine—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000244	CcSEcCtD
Mefloquine—ADORA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.98e-05	0.00056	CbGpPWpGaD
Mefloquine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000242	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.84e-05	0.000541	CbGpPWpGaD
Mefloquine—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000235	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	3.81e-05	0.000537	CbGpPWpGaD
Mefloquine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000234	CcSEcCtD
Mefloquine—Rash—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000233	CcSEcCtD
Mefloquine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000233	CcSEcCtD
Mefloquine—Headache—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000231	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.75e-05	0.000528	CbGpPWpGaD
Mefloquine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000226	CcSEcCtD
Mefloquine—ADORA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.67e-05	0.000516	CbGpPWpGaD
Mefloquine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000219	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.57e-05	0.000502	CbGpPWpGaD
Mefloquine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000217	CcSEcCtD
Mefloquine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000215	CcSEcCtD
Mefloquine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000215	CcSEcCtD
Mefloquine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000214	CcSEcCtD
Mefloquine—HBA2—Metabolism—AKT1—peripheral nervous system neoplasm	3.49e-05	0.000491	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.49e-05	0.000491	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.38e-05	0.000476	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	3.37e-05	0.000474	CbGpPWpGaD
Mefloquine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000203	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.17e-05	0.000446	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.14e-05	0.000442	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.12e-05	0.000439	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.05e-05	0.00043	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ENO2—peripheral nervous system neoplasm	3.04e-05	0.000427	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.02e-05	0.000425	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—HRAS—peripheral nervous system neoplasm	2.93e-05	0.000413	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.91e-05	0.00041	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.91e-05	0.00041	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.86e-05	0.000402	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.84e-05	0.0004	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.79e-05	0.000393	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.78e-05	0.000392	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.76e-05	0.000388	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.75e-05	0.000387	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	2.71e-05	0.000381	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.67e-05	0.000376	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—AKT1—peripheral nervous system neoplasm	2.65e-05	0.000372	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—AKT1—peripheral nervous system neoplasm	2.59e-05	0.000365	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—BCHE—peripheral nervous system neoplasm	2.57e-05	0.000361	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.53e-05	0.000356	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.45e-05	0.000344	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.43e-05	0.000341	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TH—peripheral nervous system neoplasm	2.41e-05	0.000339	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—HRAS—peripheral nervous system neoplasm	2.39e-05	0.000336	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.36e-05	0.000332	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.36e-05	0.000332	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.3e-05	0.000323	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.27e-05	0.00032	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.25e-05	0.000317	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.25e-05	0.000316	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	2.22e-05	0.000312	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.18e-05	0.000307	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.18e-05	0.000307	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TH—peripheral nervous system neoplasm	2.15e-05	0.000303	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	2.13e-05	0.0003	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.09e-05	0.000294	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.06e-05	0.00029	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.06e-05	0.000289	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.01e-05	0.000283	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.97e-05	0.000277	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000277	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ABCB1—peripheral nervous system neoplasm	1.93e-05	0.000272	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.9e-05	0.000267	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.89e-05	0.000266	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.86e-05	0.000262	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000261	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.83e-05	0.000258	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.81e-05	0.000255	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.79e-05	0.000252	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.78e-05	0.00025	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000247	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	1.72e-05	0.000243	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.47e-05	0.000207	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.47e-05	0.000206	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.46e-05	0.000205	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.43e-05	0.000202	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.38e-05	0.000194	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.34e-05	0.000189	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.34e-05	0.000189	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.33e-05	0.000187	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.32e-05	0.000186	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000181	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.25e-05	0.000175	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000175	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.24e-05	0.000175	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.22e-05	0.000172	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.13e-05	0.000159	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.12e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.07e-05	0.00015	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.07e-05	0.00015	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000148	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.000148	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.04e-05	0.000146	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.04e-05	0.000146	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.03e-05	0.000145	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1e-05	0.000141	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	9.89e-06	0.000139	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.42e-06	0.000133	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.61e-06	0.000121	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.57e-06	0.000121	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.53e-06	0.00012	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.16e-06	0.000115	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.14e-06	0.000115	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	8.08e-06	0.000114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.02e-06	0.000113	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.93e-06	0.000112	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.21e-06	0.000101	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.88e-06	9.68e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.59e-06	9.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.56e-06	9.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.47e-06	9.1e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.3e-06	8.87e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.56e-06	7.83e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—peripheral nervous system neoplasm	5.31e-06	7.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.28e-06	7.43e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.18e-06	7.29e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.88e-06	6.87e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	4.74e-06	6.67e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.31e-06	3.26e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.18e-06	3.07e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	2.01e-05	CbGpPWpGaD
